blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2234611

EP2234611 - COMPOSITION FOR TREATING STERILE INFLAMMATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.12.2012
Database last updated on 02.11.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU
published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Oy Neurofood Ab
c/o Oy Julius Tallberg Ab Suomalaistentie 7
02270 Espoo / FI
[2010/40]
Inventor(s)01 / TALLBERG, Thomas
Enåsvägen 16 A 2
FI-00200 Helsingfors / FI
 [2010/40]
Representative(s)Boije-Backman, Solveig Magdalena
Kolster OY AB
Iso Roobertinkatu 23
P.O. Box 148
00121 Helsinki / FI
[N/P]
Former [2012/06]Boije-Backman, Solveig Magdalena
Kolster Oy Ab
Iso Roobertinkatu 23
P.O. Box 148
00121 Helsinki / FI
Former [2010/40]Boije-Backman, Solveig Magdalena
Kolster Oy Ab Iso Roobertinkatu 23 P.O. Box 148
FIN-00121 Helsinki / FI
Application number, filing date08868549.017.12.2008
[2010/40]
WO2008FI50750
Priority number, dateFI2007000597128.12.2007         Original published format: FI 20075971
[2010/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009083643
Date:09.07.2009
Language:EN
[2009/28]
Type: A2 Application without search report 
No.:EP2234611
Date:06.10.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 09.07.2009 takes the place of the publication of the European patent application.
[2010/40]
Type: B1 Patent specification 
No.:EP2234611
Date:08.02.2012
Language:EN
[2012/06]
Search report(s)International search report - published on:EP29.10.2009
ClassificationIPC:A61K31/197, A61K31/198, A61K31/519, A61K33/04, A61K33/24, A61K33/30, A61K35/30, A61K45/06
[2010/40]
CPC:
A61K45/06 (EP,US); A61K31/195 (FI); A61K31/197 (EP,US);
A61K31/198 (EP,US); A61K31/519 (EP,FI,US); A61K33/00 (FI);
A61K33/04 (EP,US); A61K33/24 (EP,FI,US); A61K33/30 (EP,US);
A61K35/30 (EP,FI,US); A61P1/00 (EP); A61P1/04 (EP);
A61P17/06 (EP); A61P19/00 (EP); A61P19/02 (EP);
A61P29/00 (EP); A61P37/00 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/197, A61K2300/00 (US,EP);
A61K31/198, A61K2300/00 (US,EP);
A61K31/519, A61K2300/00 (US,EP);
A61K33/04, A61K2300/00 (US,EP);
A61K33/24, A61K2300/00 (EP,US);
A61K33/30, A61K2300/00 (EP,US);
A61K35/30, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/40]
TitleGerman:ZUSAMMENSETZUNG ZUR BEHANDLUNG STERILER ENTZÜNDUNGEN[2010/40]
English:COMPOSITION FOR TREATING STERILE INFLAMMATION[2010/40]
French:COMPOSITION POUR LE TRAITEMENT DE L'INFLAMMATION STÉRILE[2010/40]
Entry into regional phase27.07.2010National basic fee paid 
27.07.2010Designation fee(s) paid 
27.07.2010Examination fee paid 
Examination procedure04.12.2009Request for preliminary examination filed
International Preliminary Examining Authority: EP
27.07.2010Amendment by applicant (claims and/or description)
27.07.2010Examination requested  [2010/40]
11.07.2011Communication of intention to grant the patent
28.10.2011Fee for grant paid
28.10.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.07.2011
Opposition(s)09.11.2012No opposition filed within time limit [2013/03]
Fees paidRenewal fee
17.12.2010Renewal fee patent year 03
20.12.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.12.2008
BE08.02.2012
CY08.02.2012
CZ08.02.2012
EE08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
LV08.02.2012
MT08.02.2012
NL08.02.2012
RO08.02.2012
SI08.02.2012
SK08.02.2012
TR08.02.2012
BG08.05.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
[2014/34]
Former [2014/21]BE08.02.2012
CY08.02.2012
CZ08.02.2012
EE08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
LV08.02.2012
MT08.02.2012
NL08.02.2012
RO08.02.2012
SI08.02.2012
SK08.02.2012
TR08.02.2012
BG08.05.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
Former [2013/51]BE08.02.2012
CY08.02.2012
CZ08.02.2012
EE08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
LV08.02.2012
MT08.02.2012
NL08.02.2012
RO08.02.2012
SI08.02.2012
SK08.02.2012
BG08.05.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
Former [2013/33]BE08.02.2012
CY08.02.2012
CZ08.02.2012
EE08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
LV08.02.2012
NL08.02.2012
RO08.02.2012
SI08.02.2012
SK08.02.2012
BG08.05.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
Former [2012/50]BE08.02.2012
CY08.02.2012
CZ08.02.2012
EE08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
LV08.02.2012
NL08.02.2012
RO08.02.2012
SI08.02.2012
SK08.02.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
Former [2012/49]BE08.02.2012
CY08.02.2012
CZ08.02.2012
EE08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
LV08.02.2012
NL08.02.2012
RO08.02.2012
SI08.02.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
Former [2012/48]BE08.02.2012
CY08.02.2012
EE08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
LV08.02.2012
NL08.02.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
Former [2012/41]BE08.02.2012
CY08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
LV08.02.2012
NL08.02.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
Former [2012/39]BE08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
LV08.02.2012
NL08.02.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
Former [2012/37]BE08.02.2012
FI08.02.2012
HR08.02.2012
LT08.02.2012
NL08.02.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
PT08.06.2012
Former [2012/36]HR08.02.2012
LT08.02.2012
NL08.02.2012
NO08.05.2012
GR09.05.2012
IS08.06.2012
Former [2012/35]LT08.02.2012
NL08.02.2012
NO08.05.2012
IS08.06.2012
Former [2012/34]LT08.02.2012
NO08.05.2012
IS08.06.2012
Cited inInternational search[Y]EP0737471  (OREAL [FR]) [Y] 1-11 * claim 10 *;
 [Y]EP1523985  (HELSINGFORS INSTITUTION FOER B [FI]) [Y] 1-11* paragraph [0021] *;
 [I]WO2005074910  (HELSINGFORS INSTITUTION FOER B [FI], et al) [I] 1-11 * claim - *;
 [Y]  - TALLBERG T ET AL, "Development of a Combined Biological and Immunological Cancer Therapy Modality", JOURNAL OF THE AUSTRALASIAN COLLEGE OF NUTRITIONAL ANDENVIRONMENTAL MEDICINE, COLLEGE, BEAUMARIS, AU, (20030401), vol. 22, no. 1, ISSN 1328-8040, pages 3 - 21, XP002987380 [Y] 1-11 * page 15, column 1, line 18 - line 25; tables 2,5,6 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.